Navigation Links
TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City
Date:1/24/2012

CHENGDU, China, Jan. 24, 2012 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today announced that the Company's 2011 Annual Shareholder Meeting will be held at Floor 20, 17 State Street, New York, NY 10004 on Wednesday, April 11, 2012, at 10:00 am (EST).  

TPI's Board of Directors has established Monday, February 13, 2012, as the record date for determining the stockholders entitled to vote at the Annual Meeting.

Stockholder proposals must be received no later than Friday, February 17, 2012, in order to be considered for inclusion in the Company's proxy statement or to be presented at the Annual Meeting. Stockholder proposals should be mailed to Hunter Taubman Weiss LLP, c/o Tianyin Pharmaceutical Co., Inc, 17 State Street, Floor 20, New York, NY 10004.

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit:  http://www.tianyinpharma.com.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit: http://www.tianyinpharma.com, or email ir@tpi.asia

Tel:     +86-28-8551-6696 (Chengdu, China)
          +86-134-3655-0011 (China)

Address:
Tianyin Pharmaceutical
23rd Floor, Unionsun Yangkuo Plaza
No. 2, Block 3, South Renmin Road
Chengdu, 610041
China


'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
3. Leatt Holds 2011 Annual Meeting of Shareholders
4. IsZo Capital Writes to Taro Pharmaceutical Board Commenting on Management Proposals for 2011 Annual Shareholder Meeting; Reflecting on Sun Pharmas Response to Similar 2009 Proposals
5. Medco Shareholders Approve Merger With Express Scripts
6. Nutra Pharma Letter to Shareholders
7. GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation
8. IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders Meeting
9. Leatt Corporation Announces 2011 Annual Shareholders Meeting
10. Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes
11. Aethlon Medical Releases Shareholder Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... Products, a leader in medical product innovation and global patient care, ... hospice patient care. ... Centurion Medical Products ... management and emotional comfort are part of a hospice,s primary mission. ... unneeded emergency department admission due to severe fecal impaction. One of ...
(Date:7/11/2017)... Calif. , July 11, 2017 Zymo Research Corp., also ... service that can quantify biological aging in a precise manner using the ... Steve Horvath , a professor of human genetics and biostatistics at ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... 19, 2017 , ... Adolfson & Peterson Construction (AP) continues ... As a leader in healthcare construction, AP has successfully built several well-known medical ... Midwest with Josh now on board. , Josh brings over nine years ...
(Date:7/18/2017)... ... July 18, 2017 , ... CannaKids, a California Cooperative Cooperation that specializes in ... at the WORLDZ Summit, taking place in Hollywood from July 31-August 1, the ... medical cannabis for both pediatric and adult patients, and how the path has led ...
(Date:7/18/2017)... ... ... An inventor from Anacortes, Wash., knows the difficulties and indignity of not being ... I suffer from anxiety and vertigo on top of that," she said, "so I ... meets that need. , This device enables a woman in menopause to cool off ...
(Date:7/17/2017)... , ... July 17, 2017 , ... ... Depression and Its Treatments during Pregnancy , studies take a closer look at ... on a developing baby with one study showing newer medications may be safer ...
(Date:7/17/2017)... (PRWEB) , ... July 17, 2017 , ... ... medical education events, today announced a partnership with the Texas Academy of ... meeting will take place October 20-22, 2017 at the Hyatt Regency Dallas in ...
Breaking Medicine News(10 mins):